Telephone
61.3.6189.1155
Address
647 Beaufort Street Mt. Lawley, Western Australia (WA) 6050
Description
TrivarX Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. Its product is used to assist the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in 1998 and is headquartered in South Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.04
Trade Value (12mth)
AU$820.00
1 week
-9.09%
1 month
3.45%
YTD
-25%
1 year
50%
All time high
172.932
EPS 3 yr Growth
N/A
EBITDA Margin
%
Operating Cashflow
-$1m
Free Cash Flow Return
-13.90%
ROIC
-45.70%
Interest Coverage
-161.10
Quick Ratio
0.20
Shares on Issue (Fully Dilluted)
181m
HALO Sector
Technology
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 October 23 |
September 2023 Quarterly Activities Report and Appendix 4C
×
September 2023 Quarterly Activities Report and Appendix 4C |
30 October 23 |
Letter to Shareholders & Notice of AGM & Proxy Form
×
Letter to Shareholders & Notice of AGM & Proxy Form |
29 November 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
27 October 23 |
Completion of Consolidation of Capital
×
Completion of Consolidation of Capital |
20 November 23 |
Phase 2 SAMDE Study Update
×
Phase 2 SAMDE Study Update |
20 November 23 |
Application for quotation of securities - TRI
×
Application for quotation of securities - TRI |
20 November 23 |
Cleansing Notice
×
Cleansing Notice |
18 October 23 |
Consolidation/Split - TRI
×
Consolidation/Split - TRI |
17 October 23 |
Change in substantial holding
×
Change in substantial holding |
16 October 23 |
Change of Director's Interest Notice - Chris Ntoumenopoulos
×
Change of Director's Interest Notice - Chris Ntoumenopoulos |
16 October 23 |
Change of Director's Interest Notice - David Trimboli
×
Change of Director's Interest Notice - David Trimboli |
16 November 23 |
Investor Presentation - November 2023
×
Investor Presentation - November 2023 |
16 November 23 |
Proposed issue of securities - TRI
×
Proposed issue of securities - TRI |
15 November 23 |
Application for quotation of securities - TRI
×
Application for quotation of securities - TRI |
15 November 23 |
Cleansing Notice
×
Cleansing Notice |
14 November 23 |
Proposed issue of securities - TRI
×
Proposed issue of securities - TRI |
14 November 23 |
Proposed issue of securities - TRI
×
Proposed issue of securities - TRI |
14 November 23 |
Option Terms and Conditions
×
Option Terms and Conditions |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.